HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide

The use of high dose posttransplant cyclophosphamide (PT-CY) introduced by the Baltimore group approximately 10 years ago has been rapidly adopted worldwide and is becoming a standard for patients undergoing unmanipulated haploidentical (HAPLO) transplants. PT-CY has been used following nonmyeloabla...

Descripción completa

Detalles Bibliográficos
Autores principales: Bacigalupo, Andrea, Sica, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838781/
https://www.ncbi.nlm.nih.gov/pubmed/27143973
http://dx.doi.org/10.1155/2016/7802967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838781/
https://www.ncbi.nlm.nih.gov/pubmed/27143973
http://dx.doi.org/10.1155/2016/7802967

Ejemplares similares